By Max Mitchell | November 10, 2020
As attorneys across the country fight over whether to consolidate litigation over the bladder infection medication Elmiron into a single federal court, a district judge in Pennsylvania has decided that claims seeking medical monitoring over the medication can't be litigated as a national class action.
By Amanda Bronstad | November 5, 2020
The proposal, which still has to be approved by thousands of cities and counties, may have overcome a major hurdle in the negotiations for a global opioid settlement: legal fees. The deal involves three major pharmaceutical distributors and Johnson & Johnson.
The Legal Intelligencer | News
By Max Mitchell | October 21, 2020
The majority rejected arguments that the claims could not pass constitutional muster under the U.S. Supreme Court's 2017 decision in Bristol-Myers Squibb v. Superior Court of California.
By Robert Storace | October 21, 2020
The DOJ closed criminal and civil investigations with Purdue Pharma, with the company agreeing to plead guilty in New Jersey federal court to three federal criminal charges and pay more than $8 billion.
By Amanda Bronstad | October 15, 2020
Lawyers from several prominent firms have filed 80 lawsuits that allege Elmiron, used to treat a chronic bladder infection called interstitial cystitis, causes eye problems. Anticipating hundreds more cases, they are dueling over whether to coordinate an MDL in Pennsylvania before U.S. District Judge Wendy Beetlestone or U.S. District Judge Brian Martinotti in New Jersey, home to defendant Johnson & Johnson's Janssen Pharmaceuticals.
By Patrick Smith | September 11, 2020
Pausing the AstraZeneca COVID-19 vaccine trial is news, but it wasn't unexpected and pharma companies and their law firms have plans in place.
New Jersey Law Journal | Analysis
By Christine A. Gaddis | September 9, 2020
Despite the overall reduction in Hatch-Waxman cases and filings, cases have continued to move forward—albeit with COVID-19-related modifications.
By Charles Toutant | September 1, 2020
The panel found that a rule should be treated as nonjurisdictional unless Congress clearly states that it is jurisdictional. Sanofi and Bristol did not identify any language, nor did the panel see any, that plainly shows Congress imbued the first-to-file bar with jurisdictional consequences, the court said.
By Katheryn Tucker | August 31, 2020
"I've never even heard of this happening," said Chicago lawyer Eugene E. Murphy Jr., of the marathon session with the Chicago Zoning Board of Appeals, which ultimately ended in a rare ruling barring a pot dispensary from opening in the city's upscale Gold Coast neighborhood.
By Suzette Parmley | August 18, 2020
The case tests the bounds of employer arbitration contracts and if "acknowledging" an agreement is the same as "assenting" to one.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
McManimon, Scotland & Baumann, LLC is seeking talented and motivated Associate Attorneys with 3-7 years of experience working closely wi...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS